Patents by Inventor Ian Keith Winterborn

Ian Keith Winterborn has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Compositions
    Publication number: 20020197318
    Abstract: A pharmaceutical composition for oral adminstration comprising a film-coated solid dosage form including 3-[2-(dimethylamino)ethyl]-N-methyl-1H-indole-5-methanesulphonamide or a pharmaceutically acceptable salt or solvate thereof as active ingredient.
    Type: Application
    Filed: February 28, 2002
    Publication date: December 26, 2002
    Applicant: Glaxo Group Limited
    Inventors: Anthony John Phillips, Ian Keith Winterborn, John Malcolm Padfield
  • Compositions
    Patent number: 6368627
    Abstract: A pharmaceutical composition for oral adminstration comprising a film-coated solid dosage form including 3-[2-(dimethylamino)ethyl]-N-methyl-1H-indole-5-methanesulphonamide or a pharmaceutically acceptable salt or solvate thereof as active ingredient. The film-coated solid dosage forms are of use in the treatment of conditions associated with cephalic pain, in particular migraine.
    Type: Grant
    Filed: January 13, 2000
    Date of Patent: April 9, 2002
    Assignee: Glaxo Group Limited
    Inventors: Anthony John Phillips, Ian Keith Winterborn, John Malcolm Padfield
  • Ondansetron freeze-dried dosage form compositions for oral administration
    Patent number: 6063802
    Abstract: The invention relates to a freeze-dried dosage form for oral administration capable of being rapidly disintegrated in the mouth comprising ondansetron in the form of its free base or a pharmaceutically acceptable solvate thereof and one or more pharmaceutically acceptable excipients. Methods for the manufacture of such compositions and for their use in the treatment of conditions mediated through the action of 5-hydroxytryptamine (5HT) at 5HT.sub.3 receptors are also described.
    Type: Grant
    Filed: January 28, 1999
    Date of Patent: May 16, 2000
    Assignee: Glaxco Wellcome Inc.
    Inventor: Ian Keith Winterborn
  • Compositions for treating migraine
    Patent number: 6020001
    Abstract: A pharmaceutical composition for oral adminstration comprising a film-coated solid dosage form including 3-[2-(dimethylamino)ethyl]-N-methyl-1H-indole-5-methanesulphonamide or a pharmaceutically acceptable salt or solvate thereof as active ingredient.The film-coated solid dosage forms are of use in the treatment of conditions associated with cephalic pain, in particular migraine.
    Type: Grant
    Filed: July 24, 1998
    Date of Patent: February 1, 2000
    Assignee: Glaxo Group Limited
    Inventors: Anthony John Phillips, Ian Keith Winterborn, John Malcolm Padfield
  • Freeze-dried compositions
    Patent number: 5955488
    Abstract: The invention relates to a freeze-dried dosage form for oral administration capable of being rapidly disintegrated in the mouth comprising ondansetron in the form of its free base or a pharmaceutically acceptable solvate thereof and one or more pharmaceutically acceptable excipients. Methods for the manufacture of such compositions and for their use in the treatment of conditions mediated through the action of 5-hydroxytryptamine (5HT) at 5HT.sub.3 receptors are also described.
    Type: Grant
    Filed: April 28, 1998
    Date of Patent: September 21, 1999
    Assignee: Glaxo Wellcome Inc.
    Inventor: Ian Keith Winterborn
  • Oral dosage form for treating migraine
    Patent number: 5863559
    Abstract: A pharmaceutical composition for oral adminstration comprising a film-coated solid dosage form including 3-?2-(dimethylamino)ethyl!-N-methyl-1H-indole-5-methanesulphonamide or a pharmaceutically acceptable salt or solvate thereof as active ingredient.The film-coated solid dosage forms are of use in the treatment of conditions associated with cephalic pain, in particular migraine.
    Type: Grant
    Filed: January 31, 1995
    Date of Patent: January 26, 1999
    Assignee: Glaxo Group Limited
    Inventors: Anthony John Phillips, Ian Keith Winterborn, John Malcolm Padfield